ANXA1 also promotes the proliferation and metastasis of cancer cells through the binding of EphA2, the suppression of autophagy and the activation of the PI3K/AKT pathway [22,23] and promotes proliferation and migration via the regulation of the IL-6/JAK2/STAT3 pathway [24]. Here, EPHA2 is linked to cancer.